When a sponsor sits down to review your CRO RFP response, what are they actually looking for? CRO leadership teams aren't asking this enough.
The obvious answers are the ones the industry has been optimizing for years. Therapeutic experience. Site network depth. Regulatory track record. Competitive pricing. Of course, these matter, but if you talk to enough sponsors, they’ll tell you something has shifted. And more and more, the data backs this up.
The CROs winning the most competitive bids today aren't only the ones with the most sites or the lowest price. In today’s CRO competition, they're the ones who can prove operational control. Not by brute force or SOPs, but with the right tools that enable operational excellence across the board.
Key takeaways in this article:
Sponsors are under more pressure than ever. Trial complexity has increased by 22%1 over the past decade. The cost of a failed or delayed trial is measured in years and hundreds of millions of dollars. And when something goes wrong at the site level, whether it’s a protocol deviation, missed visit, or enrollment shortfall, it's the sponsor who absorbs the consequences.
This is why many sponsors now say poor risk management is a top concern when selecting a CRO. It's not that CROs have gotten worse at managing risk. It's that sponsors are increasingly asking for evidence that it can be managed well, beyond a “risk management plan” written out in a Word document.
CROs were once able to win on relationships and past performance alone. These are still important factors, but no longer enough. Sponsors want to see how you can systematically deliver operational excellence, supported by purpose-built tools that empower your entire staff, versus just relying on the heroics of your star project manager.
Here are five things sponsors now look for, beyond the usual criteria.
Sponsors want CROs who uncover problems before they're found on an audit or turn into protocol deviations. Systematic processes, not just experienced people, can identify and act on site-level risks early on. The distinction matters because experienced people retire, get promoted, or move between studies. Systems allow operational excellence to scale among your entire staff.
A common source of sponsor frustration is inconsistency across all sites. A CRO can have ten excellent sites and three that create all the headaches. Because sponsors know this, they're now asking CROs to demonstrate standardized compliance documentation and oversight across all sites.
Audit failure rates are higher for sites without structured compliance oversight. And audit findings that surface during a study reflect on the CRO just as much as the site.
#3: Reduced operational overhead for everyoneSponsor teams are lean. Study managers and medical monitors don't have unlimited time to wait for or chase down site findings, manage document requests, or manually track metrics and status updates. They're looking for CROs who can reduce the cognitive load on their side as well as on the sites.
It’s an obvious value proposition for CROs to demonstrate that their technology-supported processes reduce site staff hours and study team hours, while offering on-demand insights, transparency and performance metrics. No vague promises of efficiency are required.
#4: Real-time visibility into what's actually happening
"We'll send you the monthly report" is no longer good enough for many sponsors. The expectation for real-time dashboards, enrollment forecasting, and site engagement tracking has moved from nice-to-have features to table stakes capabilities in competitive bids. Sponsors don’t want a snapshot from weeks ago; they want to have a window into their study at any given moment.
#5: Differentiation beyond headcount and cost
This one is worth dwelling on. The CRO market is competitive, and many CROs can check the boxes on experience and site access. When capabilities are roughly equal, sponsors start making decisions based on confidence, communication, and as we're seeing more often, technology sophistication.
A CRO that can demonstrate a structured, technology-enabled approach to site activation, enrollment, and site & patient engagement tells a different story than one that leads with head count. Both might be equally capable of executing the study. But one of them positions themselves like the more controlled, disciplined partner.
🔍 Explore ProofPilot’s platform to see how we'll help you achieve all of this and more.
It's becoming clear: the CROs who have invested in technology-enabled workflows—whether through proprietary tools or through white-label partnerships—are better able to speak to all five of these sponsor priorities. They can show the dashboard. They can cite the enrollment KPIs. They can walk a sponsor through crystal clear site training and activation metrics.
The CROs who haven't made that investment are left answering these questions with manual processes that take too much time.
If you're leading a CRO BD effort or clinical operations team, the question to ask isn't "do we need technology?" It's "what does our operational technology story look like when a sponsor asks? Or are we going to tell them we have manual spreadsheets for everything?"
A few places to start:
Audit your current RFP responses. How specifically do you address risk management, site compliance oversight, and real-time visibility? Do your data and workflows support your answers?
Talk to your sites. Site feedback about what's working and what's creating friction is often exactly the same feedback that sponsors get. Sponsors notice the downstream effects when sites struggle with training, document tasks, or communication that rely solely on manual efforts.
Look at your enrollment data honestly. Sponsors are watching site activation distribution, screening rates, referral-to-randomize ratios, screen failure ratios, # of days-to-call-referrals and more. If you can’t accurately measure these, you can’t effectively manage them.
Ask whether your technology story holds up. When a sponsor asks how you track and manage site engagement across your network, are you proud of your answer? Can you show them real dashboards? Or is it something you're hoping they don't press on because they’re Excel tables and PowerPoints?
Overall, sponsors haven't changed what they want from a CRO. They want their studies delivered on time, within budget, with clean data and minimal surprises. What's changed is how they're evaluating whether a CRO can actually deliver that.
The bar for demonstrating operational control has risen. CROs who prioritize structured workflows, compliant documentation, and real-time visibility are the ones who will continue to win the most competitive business.
That's not a technology story. That's a business development story. The right technology is why they will believe it.
ProofPilot works with clinical trial sponsors and CROs to simplify site activation, enrollment, and engagement across the study lifecycle. Exploring how to strengthen your CRO's operational story? Schedule a quick call with us today.
1. https://pmc.ncbi.nlm.nih.gov/articles/PMC10861486/
What has changed in how sponsors evaluate CRO RFPs?
Sponsors still want on-time, on-budget studies with clean data, but the bar for proving you can deliver has risen. With trial complexity up 22% and a high cost of delays, sponsors now prioritize evidence of operational control and real-time transparency. Relationships and past performance remain important, yet they’re no longer sufficient without demonstrable, tech-enabled processes that scale beyond individual “hero” project managers.
What does "proving operational control" look like in a CRO RFP response?
It means showing systematic, technology-enabled workflows that:
How can a CRO strengthen its technology story before the next RFP?
Start by: